Medical perspective Here are a few practical strategies to make injections smoother, less intimidating, and more comfortable: Practice without medication: Use a demo pen or practice device to familiarize yourself with the feel and steps before your first real dose
That early signal is part of what keeps people consistent through the slower middle stretch
Among 169,649 patients with MASLD, GLP-1 receptor agonist initiation was linked to significantly lower probability of incident cirrhosis [adjusted hazard ratio (aHR): 0.86, 95%CI: 0.80-0.93], hepatic decompensation (aHR: 0.77, 95%CI: 0.65-0.90), and hepatocellular carcinoma (HCC) (aHR: 0.79, 95%CI: 0.68-0.92) over a median follow-up of 3.5 years compared to non-users
Adherence to the regimen is encouraged to effectively replete or maintain vitamin levels, but occasional timing adjustments are acceptable
Since the approval of the first GLP-1 RA by the Food and Drug Administration (FDA) in 2005 (exenatide), several GLP-1 receptor agonist drugs have been widely used in clinical practice